Tenaya Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
TNYA Nasdaq 8731 https://www.tenayatherapeutics.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Tenaya Therapeutics Inc

With 35% stake, Tenaya Therapeutics, Inc. (NASDAQ:TNYA) seems to have captured institutional investors' interest - May 30th, 2023 1:06 pm
Wall Street Analysts Believe Tenaya Therapeutics, Inc. (TNYA) Could Rally 217.58%: Here's is How to Trade - May 15th, 2023 1:55 pm
Tenaya Therapeutics, Inc. (TNYA) Is a Great Choice for 'Trend' Investors, Here's Why - May 11th, 2023 12:50 pm
Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update - May 10th, 2023 8:19 pm
Tenaya Highlights Growing Capabilities in AAV Manufacturing, Capsid Engineering and Expansion into Gene Editing with Six Abstracts Accepted for Presentation at the ASGCT 26th Annual Meeting - May 3rd, 2023 12:00 pm
We Think Tenaya Therapeutics (NASDAQ:TNYA) Needs To Drive Business Growth Carefully - May 3rd, 2023 11:09 am
Tenaya Therapeutics Receives FDA Fast Track Designation for TN-201 - May 2nd, 2023 11:50 am
The 7 Best Biotech Stocks for Personalized Medicine Investors - Apr 25th, 2023 10:35 am
3 Penny Stocks to Buy for 100% Returns - Apr 23rd, 2023 8:02 pm
Tenaya Therapeutics to Participate at Chardan's 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit - Apr 21st, 2023 8:05 pm
Why This Nasdaq Stock Caught Fire This Week - Apr 20th, 2023 6:46 pm
These 2 ‘Strong Buy’ Penny Stocks Could Rally to $40 (or More), Says Piper Sandler - Apr 19th, 2023 3:36 pm
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update - Mar 8th, 2023 9:01 pm
Tenaya Therapeutics to Participate in Upcoming Investor Conferences - Feb 7th, 2023 10:17 pm
Tenaya Therapeutics, Inc. (TNYA) Upgraded to Buy: Here's What You Should Know - Jan 26th, 2023 5:00 pm
Tenaya Therapeutics Announces TN-201 IND Clearance and Anticipated 2023 Milestones - Jan 9th, 2023 12:00 pm
Insiders who placed huge bets on Tenaya Therapeutics, Inc. (NASDAQ:TNYA) earlier this year would be disappointed with the 23% drop - Dec 21st, 2022 11:12 am
Tenaya Therapeutics Appoints Amy Burroughs to Board of Directors - Dec 7th, 2022 9:30 pm
Tenaya Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for its Gene Therapy for Genetic Arrhythmogenic Right Ventricular Cardiomyopathy - Nov 28th, 2022 1:30 pm
Here's Why Tenaya Therapeutics (NASDAQ:TNYA) Must Use Its Cash Wisely - Nov 24th, 2022 10:54 am